|
1
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeng X and Tao H: Diagnostic and
prognostic serum marker of cholangiocarcinoma (Review). Oncol Lett.
9:3–8. 2015.PubMed/NCBI
|
|
3
|
Rizvi S and Gores GJ: Pathogenesis,
diagnosis, and management of cholangiocarcinoma. Gastroenterology.
145:1215–1229. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rizvi S and Gores GJ: Molecular
pathogenesis of cholangiocarcinoma. Dig Dis. 32:564–569. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fujiwara M, Kanayama K, Hirokawa YS and
Shiraishi T: ASF-4-1 fibroblast-rich culture increases
chemoresistance and mTOR expression of pancreatic cancer BxPC-3
cells at the invasive front in vitro, and promotes tumor growth and
invasion in vivo. Oncol Lett. 11:2773–2779. 2016.PubMed/NCBI
|
|
6
|
Kodama J Hasengaowa, Kusumoto T, Shinyo Y,
Seki N, Nakamura K, Hongo A and Hiramatsu Y: Loss of basement
membrane heparan sulfate expression is associated with tumor
progression in endometrial cancer. Eur J Gynaecol Oncol.
26:403–406. 2005.PubMed/NCBI
|
|
7
|
Paduch R: The role of lymphangiogenesis
and angiogenesis in tumor metastasis. Cell Oncol (Dordr).
39:397–410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Christiansen A and Detmar M:
Lymphangiogenesis and cancer. Genes Cancer. 2:1146–1158. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakamura Y, Yasuoka H, Tsujimoto M, Imabun
S, Nakahara M, Nakao K, Nakamura M, Mori I and Kakudo K: Lymph
vessel density correlates with nodal status, VEGF-C expression, and
prognosis in breast cancer. Breast Cancer Res Treat. 91:125–132.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Al-Shareef H, Hiraoka SI, Tanaka N, Shogen
Y, Lee AD, Bakhshishayan S and Kogo M: Use of NRP1, a novel
biomarker, along with VEGF-C, VEGFR-3, CCR7 and SEMA3E, to predict
lymph node metastasis in squamous cell carcinoma of the tongue.
Oncol Rep. 36:2444–2454. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schoppmann SF, Berghoff A, Dinhof C,
Jakesz R, Gnant M, Dubsky P, Jesch B, Heinzl H and Birner P:
Podoplanin-expressing cancer-associated fibroblasts are associated
with poor prognosis in invasive breast cancer. Breast Cancer Res
Treat. 134:237–244. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan P, Temam S, El-Naggar A, Zhou X, Liu
DD, Lee JJ and Mao L: Overexpression of podoplanin in oral cancer
and its association with poor clinical outcome. Cancer.
107:563–569. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takahashi A, Ishii G, Neri S, Yoshida T,
Hashimoto H, Suzuki S, Umemura S, Matsumoto S, Yoh K, Niho S, et
al: Podoplanin-expressing cancer-associated fibroblasts inhibit
small cell lung cancer growth. Oncotarget. 6:9531–9541. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ono S, Ishii G, Nagai K, Takuwa T, Yoshida
J, Nishimura M, Hishida T, Aokage K, Fujii S, Ikeda N and Ochiai A:
Podoplanin-positive cancer-associated fibroblasts could have
prognostic value independent of cancer cell phenotype in stage I
lung squamous cell carci: Usefulness of combining analysis of both
cancer cell phenotype and cancer-associated fibroblast phenotype.
Chest. 143:963–970. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choi SY, Sung R, Lee SJ, Lee TG, Kim N,
Yoon SM, Lee EJ, Chae HB, Youn SJ and Park SM: Podoplanin, α-smooth
muscle actin or S100A4 expressing cancer-associated fibroblasts are
associated with different prognosis in colorectal cancers. J Korean
Med Sci. 28:1293–1301. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Noren NK, Liu BP, Burridge K and Kreft B:
p120 catenin regulates the actin cytoskeleton via Rho family
GTPases. J Cell Biol. 150:567–580. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Martin-Villar E, Scholl FG, Gamallo C,
Yurrita MM, Muñoz-Guerra M, Cruces J and Quintanilla M:
Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a
small membrane mucin induced in oral squamous cell carcinomas. Int
J Cancer. 113:899–910. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith SM and Melrose J: Podoplanin is
expressed by a sub-population of human foetal rib and knee joint
rudiment chondrocytes. Tissue Cell. 43:39–44. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ghosh M, Song X, Mouneimne G, Sidani M,
Lawrence DS and Condeelis JS: Cofilin promotes actin polymerization
and defines the direction of cell motility. Science. 304:743–746.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chronopoulos A, Robinson B, Sarper M,
Cortes E, Auernheimer V, Lachowski D, Attwood S, García R, Ghassemi
S, Fabry B, et al: ATRA mechanically reprograms pancreatic stellate
cells to suppress matrix remodelling and inhibit cancer cell
invasion. Nat Commun. 7:126302016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fukuoka J, Dracheva T, Shih JH, Hewitt SM,
Fujii T, Kishor A, Mann F, Shilo K, Franks TJ, Travis WD and Jen J:
Desmoglein 3 as a prognostic factor in lung cancer. Hum Pathol.
38:276–283. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kyzas PA, Geleff S, Batistatou A, Agnantis
NJ and Stefanou D: Evidence for lymphangiogenesis and its
prognostic implications in head and neck squamous cell carcinoma. J
Pathol. 206:170–177. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
The National Academies Collection, .
Reports funded by National Institutes of Health: National Research
Council (US) Committee for the Update of the Guide for the Care and
Use of Laboratory AnimalsGuide for the Care and Use of Laboratory
Animals. National Academy of Sciences. 8th. Washington (DC):
National Academies Press (US); 2011
|
|
24
|
Wang M, Wu CP, Pan JY, Zheng WW, Cao XJ
and Fan GK: Cancer-associated fibroblasts in a human HEp-2
established laryngeal xenografted tumor are not derived from cancer
cells through epithelial-mesenchymal transition, phenotypically
activated but karyotypically normal. PLoS One. 10:e01174052015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou F, Xu Y, Shi J, Lan X, Zou X, Wang L
and Huang Q: Expression profile of E-cadherin, estrogen receptors,
and P53 in early-onset gastric cancers. Cancer Med. 5:3403–3411.
2016. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gandou C, Harada K, Sato Y, Igarashi S,
Sasaki M, Ikeda H and Nakanuma Y: Hilar cholangiocarcinoma and
pancreatic ductal adenocarcinoma share similar histopathologies,
immunophenotypes, and development-related molecules. Hum Pathol.
44:811–821. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
DeOliveira ML, Cunningham SC, Cameron JL,
Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ and Schulick
RD: Cholangiocarcinoma: Thirty-one-year experience with 564
patients at a single institution. Ann Surg. 245:755–762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nimura Y, Kamiya J, Kondo S, Nagino M,
Uesaka K, Oda K, Sano T, Yamamoto H and Hayakawa N: Aggressive
preoperative management and extended surgery for hilar
cholangiocarcinoma: Nagoya experience. J Hepatobiliary Pancreat
Surg. 7:155–162. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wicki A and Christofori G: The potential
role of podoplanin in tumour invasion. Br J Cancer. 96:1–5. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pietras K and Ostman A: Hallmarks of
cancer: Interactions with the tumor stroma. Exp Cell Res.
316:1324–1331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rajaram M, Li J, Egeblad M and Powers RS:
System-wide analysis reveals a complex network of tumor-fibroblast
interactions involved in tumorigenicity. PLoS Genet.
9:e10037892013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kadota K, Huang CL, Liu D, Nakashima N,
Yokomise H, Ueno M and Haba R: The clinical significance of the
tumor cell D2-40 immunoreactivity in non-small cell lung cancer.
Lung Cancer. 70:88–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chuang WY, Yeh CJ, Wu YC, Chao YK, Liu YH,
Tseng CK, Chang HK, Liu HP and Hsueh C: Tumor cell expression of
podoplanin correlates with nodal metastasis in esophageal squamous
cell carcinoma. Histol Histopathol. 24:1021–1027. 2009.PubMed/NCBI
|
|
34
|
Kalluri R: The biology and function of
fibroblasts in cancer. Nat Rev Cancer. 16:582–598. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Navarro A, Perez RE, Rezaiekhaligh M,
Mabry SM and Ekekezie II: T1alpha/podoplanin is essential for
capillary morphogenesis in lymphatic endothelial cells. Am J
Physiol Lung Cell Mol Physiol. 295:L543–L551. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Astarita JL, Cremasco V, Fu J, Darnell MC,
Peck JR, Nieves-Bonilla JM, Song K, Kondo Y, Woodruff MC, Gogineni
A, et al: The CLEC-2-podoplanin axis controls the contractility of
fibroblastic reticular cells and lymph node microarchitecture. Nat
Immunol. 16:75–84. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Collazo J, Zhu B, Larkin S, Martin SK, Pu
H, Horbinski C, Koochekpour S and Kyprianou N: Cofilin drives
cell-invasive and metastatic responses to TGF-β in prostate cancer.
Cancer Res. 74:2362–2373. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Torka R, Thuma F, Herzog V and Kirfel G:
ROCK signaling mediates the adoption of different modes of
migration and invasion in human mammary epithelial tumor cells. Exp
Cell Res. 312:3857–3871. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ochoa-Alvarez JA, Krishnan H, Pastorino
JG, Nevel E, Kephart D, Lee JJ, Retzbach EP, Shen Y, Fatahzadeh M,
Baredes S, et al: Antibody and lectin target podoplanin to inhibit
oral squamous carcinoma cell migration and viability by distinct
mechanisms. Oncotarget. 6:9045–9060. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yoshida T, Ishii G, Goto K, Neri S,
Hashimoto H, Yoh K, Niho S, Umemura S, Matsumoto S, Ohmatsu H, et
al: Podoplanin-positive cancer-associated fibroblasts in the tumor
microenvironment induce primary resistance to EGFR-TKIs in lung
adenocarcinoma with EGFR mutation. Clin Cancer Res. 21:642–651.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Friedl P and Wolf K: Tumour-cell invasion
and migration: Diversity and escape mechanisms. Nat Rev Cancer.
3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zheng X, Carstens JL, Kim J, Scheible M,
Kaye J, Sugimoto H, Wu CC, LeBleu VS and Kalluri R:
Epithelial-to-mesenchymal transition is dispensable for metastasis
but induces chemoresistance in pancreatic cancer. Nature.
527:525–530. 2015. View Article : Google Scholar : PubMed/NCBI
|
